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CydDC is an ATP-binding Cassette (ABC) transporter found within Escherichia coli (E. 
coli), previously demonstrated to be important for the maintenance of the redox poise of the 
periplasm through the active transport of cysteine and glutathione. cydDC knockout strains 
have previously been reported to be unable to assemble bd-type respiratory oxidases, lack 
motility, and are sensitive to benzylpenicillin and nitrosative stress. Previous work has 
identified a unique haem bound to the heterodimeric CydDC complex, hypothesised to bind 
to CydD at amino acid residues Arginine 47 and Histidine 51. In the current work, UV 
spectroscopic analysis of purified CydDC confirmed the presence of bound haem and 
tryptophan fluorescence titrations revealed a high affinity of CydDC for haem with a Kd of 
0.32 µM. A CydDC expression vector was modified to encode a H51A variant of CydDC, 
but this mutation resulted in loss of assembly of the CydDC complex, indicating an important 
role for Histidine 51 of CydD in the complex assembly. Finally, disk diffusion assays were 
consistent with a role of CydDC in exporting glutathione:metal conjugates, reflecting a 
potentially novel role for CydDC in metal tolerance. 
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The periplasm of Escherichia coli (E. coli) is the assembly site for essential proteins involved 
in the processes of pathogenicity, respiration and resistance mechanisms (Holyoake, Poole 
and Shepherd 2015). Protein assembly is made possible through maintenance of the redox 
poise, created through efflux of thiol-containing molecules like cysteine and glutathione 
(GSH), which are exported via the ATP-binding cassette (ABC) transporter, CydDC 
(Pittman et al. 2002; Pittman, Robinson and Poole 2005).  
CydDC is closely related to cytochrome bd-I terminal oxidase, CydAB. Within the inner 
membrane two integral membrane terminal oxidases are present, cytochromes -bo', –bd-type 
oxidases (bd-I and bd-II), and are essential for respiration. The two terminal oxidases of E. 
coli are regulated differentially by oxygen tension (Georgiou et al. 1987). Investigations into 
the terminal oxidases have shown that under aerobic conditions, expression favours the 
assembly cytochrome bo. However, under micro-aerobic conditions expression is favoured 
towards cytochrome bd-type oxidases. Furthermore, it has been shown that CydDC is 
essential for correct assembly of bd-type terminal oxidases, with cydDC strains exhibiting 
phenotypes similar to the dsbAB strains. i.e. decreased motility, regained susceptibility to 
benzylpenicillins and incorrect assembly of bd-type terminal oxidases (Georgiou, Fang and 
Gennis 1987). The link between CydDC and bd-type cytochromes, suggest CydDC is likely 
to play a role in to resistance to nitric oxide, through aiding the correct folding of cytochrome 
bd-I and through the active efflux of cysteine and GSH, which are known to form S-
nitrosothiols (Shepherd 2015). 
1.1. Regulation and interactions of the cydDC operon 
In E. coli, the trxB gene is located upstream the cydDC operon (Figure 1.1). This gene 
encodes for a thioredoxin reductase, an enzyme involved in facilitation of reducing power 
to the periplasmic disulphide folding machinery. E. coli cydDC strains exhibit over-oxidised 
periplasms, supporting the hypothesis that CydDC maintains the redox homeostasis of the 
periplasm (Cook, Membrillo-Hernandez and Poole 1997). Primer extension of cydD mRNA 
identified a transcriptional start site 68 bp upstream of the cydDC operon. Further to this, 
northern blot analysis revealed that cydDC transcription is polycistronic; both proteins are 
encoded by a single strand of mRNA (Cook, Membrillo-Hernandez and Poole 1997). This 
study also characterised expression levels of cydDC under a variety of environmental 
conditions. Under aerobic conditions cydD transcription was 2.5-fold higher in the stationary 
phase. However, under anaerobic conditions cydD expression levels were five-fold lower, 
suggesting that cydDC transcription is regulated by oxygen tension (Cook, Membrillo-
Hernandez and Poole 1997). cydDC transcription was also shown to be independent of 
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cydAB transcription (Tseng, Albrecht and Gunsalus 1996). Moreover, Cook etl al (1997) 
showed that under microareobic conditions, cydDC expression in E. coli is elevated in the 
presence of electron acceptors, such as nitrates and fumarates and failed to assembly both c-
type cytochromes and bd-type terminal oxidases (Cook, Membrillo-Hernandez and Poole 
1997). Due to elevated expression of cydDC in the presence of nitrates and fumarates, effects 
of mutations lead to investigations into the two-component regulatory system narL and narP. 
narL and narP are transcription factors that are regulated in response to nitrate and nitrite 
(Darwin et al. 1997). It was shown that mutations within both narL and narP together and 
narL alone, significantly decreased expression of cydDC. Whereas mutations just within 
narP elicited no effect on gene expression of cydDC (Cook, Membrillo-Hernandez and 
Poole 1997). Moreover, analysis of the cydDC promoter region revealed a binding site 
closely resembling the consensus sequence of narL (Figure 1.1.) (Cook et al. 1997). These 
results suggest the role of CydDC is to assist in the active growth in varying oxygen levels.  
 
 
Figure 1.1. The cydDC operon and its proximity to trx, adapted from (Holyoake, 2015). 
 
1.2. Membrane topology of CydDC 
The CydDC complex is a heterodimeric ABC transporter consisting of proteins CydC 
(63kDA) and CydD (65kDa), that exhibit 27% homology (Shepherd 2015). The role in 
which CydDC complexes are thought to contribute to the regulation and maintenance of the 
redox poise of the periplasm remains widely unknown. The cydAB operon encodes for the 
terminal oxidases –bd, however cydDC mutant strains of E. coli show loss of –bd 
cytochromes as well as loss of cytochromes type b and c (Poole, Gibson and Wu 1994; 
Goldman, Gabbert and Kranz 1996). Therefore, it was hypothesised that CydDC imported 
haem into the periplasm for integration into c- type cytochromes (Pittman et al. 2002).  
To investigate the hypothesis, cydDC knockout strains of E. coli were investigated though 
whole cell spectra. Cook et al (2002) discovered that cydDC strains accumulated haem 
within the periplasm, equally within overexpressed cydDC strains addition of ATP revealed 
no increase in haem accumulation within the periplasm. Therefore, it was hypothesised that 
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haem transport into the periplasm occurs via one of two methods: (i) Passive binding and 
crossing of the membrane, or (ii) transportation via an unknown transporter. The 
mechanisms of haem translocation to the periplasm are still unknown. 
1.3. Structural investigations of CydDC 
The identification of CydDC’s heterodimeric topology was supported through cytochrome 
bd-I knockouts, producing no phenotypic differences within the periplasm on GSH or 
cysteine transport. This suggests that transcription of cytochrome bd-I and cydDC are 
independent of one another (Georgiou et al., 1987). Earlier investigations involving 
phylogenetic studies and hydrophobicity plots hypothesized CydDC to contain six 
membrane-spanning helices, with C and N terminal domains facing the cytoplasm (Figure 
1.2). Each subunit of the CydDC complex was hypothesised to contain nucleotide binding 
domains (NBDs) (Cook, Membrillo-Hernandez and Poole 1997). ABC transporters are 
known to possess highly conserved NBDs, that are used in the hydrolysis of Adenosine 
triphosphate (ATP) to Adenosine diphosphate (ADP). These domains are Walker A and B 
motifs Blue and green, respectively (Figure 1.2.). The energy from the hydrolysis of ATP 
to ADP is utilised by ABC transporters, such as CydDC, to transport substrates.  
Purification of wild type CydDC over expressed in BL21 cells revealed, co-purification of a 
b-type haem. Two dimensional crystallisation studies of CydDC, analysed through electron 
microscopy and circular dichroism (CD), revealed two domains of differing densities, 
providing strong evidence that CydDC is a heterodimeric ABC transporter, composed of 
mainly alpha helices (Yamashita et al. 2014).  




Figure 1.2. – Hypothesised topology of membrane bound wild type CydDC complex, in E. coli. Walker A (blue) and Walker B (green), associated with 
phosphate binding are located within the cytoplasm for ATP hydrolysis, fuelling the transportation of thiols from the cytoplasm to the periplasm for 
maintenance of the redox poise. Hypothesised haem binding domain, Histidine 51 (Red) is located on the periplasmic loop of CydD and is thought to attract 
bind the central iron core of haem, whilst the proximal Arginine is thought to stabilised haem binding through stabilisation of the carboxyl group of b-type 
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1.4. P-574, a novel haem compound 
Overexpression of CydDC complexes in anaerobic environments, revealed a peak at 574 nm 
in absorbance spectra studies; likely to be haem. Whole cell fragmentations showed 
decreases levels of P-574 with increased peaks at 560 nm. Overexpression was additionally 
shown to recover cytochrome b and c biosynthesis, as well as revealing P-574 was membrane 
bound (Cook et al. 2002), suggesting P-574 is involved in the expression of CydDC and 
cytochrome biogenesis.  
It is hypothesised that the redox environment in the periplasm is important for cytochrome 
biogenesis, tolerance to oxidative and nitrosative stress, and folding of disulphide bonds, 
which are present in many proteins involved in E. coli pathogenesis, including flagellar P-
ring motor proteins and type III secretion systems. Hence, CydDC has an important role for 
it maintains the oxidative environment of the periplasms that allows the correct folding of 
these proteins (Shepherd 2015). 
CydDC purification revealed a heterodimeric protein on SDS-PAGE gel analysis, around 55 
kDa; lower than the predicted molecular weight. Further UV spectral analysis revealed a 
peaks at 280 nm, the CydDC complex, and 415 nm, suggesting CydDC is purified with a 
covalent bound haem (Yamashita et al. 2014). The haem, thought to be a cofactor, is 
hypothesised to be bind at amino acid residue histidine (His51) and arginine (Arg47), located 
on the initial periplasmic loop of CydD (Figure 1.3.). Analysis of adjacent amino acids 
revealed  a charged central pore in which His51 resides surrounded by a hydrophobic 
opening; a common feature of haem binding sites (Shepherd 2015). Hence, His51 is a 
primary candidate for haem binding on CydD.  
It is also thought that haem has an important role in the regulation of the redox poise of the 
periplasm, and tolerance to oxidative and nitrosative stress, due to oxygen binding capacity 
of haem (Cook et al. 2002). Relating back to CydDC role in oxygen tension it may reveal 
that haem plays an important role in the activity of CydDC during various aerobic 
environments.  
1.5. Interactions of CydDC with haem 
Purified WT CydDC complexes have previously been subjected to ATPase activity assays 
in the presence of haem, this research concluded that haem interacts with CydDC. Resulting 
in increased turnover of ATPase activity of the protein, with maximal activity reached at a 
haem:protein ratio of 5:1. Further to this excess concentrations of haem exhibited inhibitory 
7 | P a g e  
 
effects on ATPase activity(Yamashita, 2015). Addition of GSH to the assays of haem:protein 
ratios over 5:1 alleviated inhibitory affects, suggesting strong synergistic stimulation of 
ATPase activity between haem and GSH. However, the effect of thiols is only to increase 
the turnover rate of ATPase cycle and not the binding of haem to CydDC. Concurrently, it 
was also shown that the binding of haem enhanced the transport of low molecular weight 
thiols across the inner membrane into the periplasm. Knowing that GSH molecules interact 
with cysteine amino acid residues of haem,  it is hypothesised that GSH and thiol stimulation 
of haem enhances CydDC transport activity, increasing transition to a reducing environment; 
facilitating disulphide bond formation and correct isomerisation.  
Further investigations into the binding of haem b showed tight interactions between CydDC 
and haem. Attempts to substitute haem b with haemin failed, suggesting tight interaction 
within the complex. It is therefore hypothesised that CydDC conformation may result from 
unknown factors other than haem binding (Yamashita et al. 2014).   
These observations raised important questions: (i) is haem co-transported with thiol 
compounds by CydDC, or does haem binding facilitate enhanced transportation of thiol 
compounds into the periplasm? (ii) is haem important in the regulation of activity of CydDC 
efflux?  
 
Figure 1.3. The hypothesized haem (Red) interaction located on the initial periplasmic loop 
of cydD, on His51 (Pink) and Arg47 (Green), (Shepherd 2015). 
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1.6. Reductant export 
1.6.1. Cysteine transport 
CydDC-mediated uptake of cysteine into the periplasm was demonstrated using CydD 
knockout strains within an orf299 background (Pittman et al. 2002). orf299 encodes for a 
transporter of the major facilitator superfamily, a group of proteins known to export and 
import small molecules, and has subsequently been shown to play a role in cysteine export 
(Daßler et al. 2000). The addition of ATP showed a significant increase in uptake of cysteine 
into the periplasm, and while the main aim of the study was to identify the substrate exported 
by CydDC, they discovered the translocation of cysteine into the periplasm via CydDC 
(Pittman et al. 2002), which is now hypothesised to assist in the homeostasis of the redox 
microenvironment (Figure 1.4).  
Given the close interplay of CydDC and Dsb proteins (Figure 1.5), mutations within both 
cydDC and dsb genes share similar phenotypes from: hypersensitivity to benzylpenicillins 
and DTT, and failure to assemble cytochrome b and c (Pittman, Robinson and Poole 2005). 
This suggests that CydDC provides the power to produce a reducing environment to facilitate 
disulphide bond formation within proteins and cytochrome assembly. Loss of CydDC also 
displays an inability to assemble cytochrome bd, the electron transfer protein to facilitate 
DsbB-mediated re-oxidation of DsbA within the disulphide bond formation pathway 
(Figure 1.5) (Pittman, Robinson and Poole 2005). The redox microenvironment of the 
periplasm was also thought to play an important role in the correct folding of disulphide 
bonds within the periplasm through the DsbA pathway, subsequently reducing sensitivity to 
antibiotics like benzylpenicillin (Pittman et al. 2002; Pittman, Robinson and Poole 2005). 
Reduction in sensitivity to benzylpenicillins can be explained through the structure of 
penicillin-binding protein (PBP) 4 (Pittman et al. 2002; Pittman, Robinson and Poole 2005). 
PBP4 has the potential to form two disulphide bonds within its active site when folded 
incorrectly, increasing affinity to penicillin (Missiakas and Raina 1997). Binding of 
penicillins to PBPs inactivates transpeptidation of peptidoglycan amino acid side chains, and 
activation of autolysins. Subsequently activation of autolysins causes degradation of 
peptidoglycan layers and lysis of bacteria due to differential osmotic pressure. Incorrect 
disulphide bond formation, controlled and regulated through the Dsb pathway, and 
influenced greatly by the efflux of thiols via CydDC, explains the increase in susceptibility 
of benzylpenicillin seen within cydDC and dsb mutants.  
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Therefore, to test the effects of cydDC mutants on antibiotic resistance, the WT strain 
(AN2342) was compared to the cydDC strain (AN2343). Both strains were plated in agar 
with 20µg ml-1 and in the presence or absence of 2mM cysteine. In the presence of cysteine 
the cydDC mutants showed a recovery against benzylpenicillin, suggesting that the role of 
CydDC complexes in E. coli play an important role in the resistance and recovery against 
antibiotics.  
1.6.2. Glutathione transport 
Reduced glutathione (GSH) is thought to play an important role within the disulphide folding 
pathways of DsbA, DsbB and DsbD, and cytochrome c biogenesis (Pittman et al. 2005, 
Fabianek et al., 2000). The first obervation that GSH plays a role in the tolerance to oxidative 
stress and xenobiotics came from the study of GSH deficient strains of E. coli that were 
hypersensitive to hypochlorous acids (Chesney, Eaton and Mahoney 1996). Using cydDC 
mutant strains (AN2343) and WT strains (AN2342), GSH uptake was measured both with 
and without the addition of ATP. After addition of the ATP, the uptake of GSH was rapid, 
reaching maximal uptake within 5 min of addition (Pittman, Robinson and Poole 2005). 
With cysteine also being exported via CydDC, as well as GSH (Figure 1.4), it was 
hypothesized that external GSH may also play a role in recovering the resistance to 
penicillin’s in cydDC mutant strains of E. coli. In the presence of GSH, the cydDC mutants 
showed a recovery against penicillin-G, supporting the hypothesis that CydDC plays an 
important role in antibiotic resistance in E. coli.  
1.6.3. Interaction of Export Products 
As previously mentioned, disulphide bond proteins (Dsb) are extremely important in the role 
of cytochrome biogenesis. Coupled with the Dsbs are cytochrome maturation proteins 
(Ccm), such as cytochrome c maturation proteins (Ccm A - G). The cytochrome maturation 
proteins’ key functions are involved in the formation of correctly folded proteins containing 
disulphide bonds through reduction of disulphide bonds, through unknown mechanisms 
(Stevens, Gordon and Ferguson 2004). Evidence provided by Stevens (2004) indicates that 
over production of Ccm proteins restores the maturation of cytochrome c in DsbD knock out 
strains. 
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Figure 1.4. CydDC exports glutathione and cysteine from the cytoplasm to the periplasm, 
to maintain the redox environment of the periplasmic space, important to facilitate 
disulphide bond formation in essential proteins.  
1.7. Physiological impact of CydDC 
1.7.1. Protein disulphide folding 
Protein disulphide folding is catalysed by Dsb proteins (Inaba 2009), and it is important for 
the correct folding and function of proteins involved in virulence, motility, and survival of 
E. coli such as, type III secretory systems, heat stable proteins, pili, flagella P-ring motors 
and adhesion factors (Yu and Kroll 1999). All of the Dsb proteins are located within the 
inner membrane or periplasm of E. coli and all contain Cysteine – X – X – Cysteine amino 
acid motifs (Yu and Kroll 1999). Dsb proteins have also been shown to play crucial roles in 
the maintenance of the redox poise, with mutations in genes encoding Dsb proteins, resulting 
in increased sensitivity to reducing agents (Missiakas and Raina 1997).The Dsb machinery 
can be split into two pathways: the oxidative pathway and the isomerisation pathway (Figure 
1.5).  
DsbA catalyses oxidative protein folding, with oxidised DsbA being regenerated via 
donating electrons to DsbB, which subsequently reduces the respiratory electron carrier 
coenzyme Q. From here, reduced Coenzyme Q can donate electrons to bd-type respiratory 
oxidases, which intriguingly, require CydDC for their assembly (Inaba 2009).  
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The isomerisation pathway involved in disulphide folding occurs through reduction of 
disulphide bonds via DsbC. This pathway is essential for the restoration of correct disulphide 
bonds within misfolded proteins, which can occur in proteins containing more than one 
disulphide bond during the disulphide formation pathway involving DsbA. The 
isomerisation pathway consists of two major Dsb proteins: DsbC and DsbD (Inaba 2009). 
DsbC contains a Cys – X – Cys active site and only exerts isomerase activity when in a 
reduced state, which is maintained by DsbD. DsbD, an inner membrane protein, that 
maintains DsbC activity through an electron transport pathway involving transport of 
electrons from Trx A to DsbD and finally to DsbC (Missiakas and Raina 1997). DsbD also 
supports the activity of DsbE/CcmG, which reduces apocytochromes and plays a vital role 
in cytochrome maturation (Fabianek, Hennecke and Thony-Meyer 1998). Maintenance of 
the reduced state of DsbC occurs from another Dsb protein, DsbG. DsbG was hypothesised 
to be an essential protein in E. coli. However, recent studies indicate that DsbG is not 
essential for growth, but primarily acts upon the maintenance of DsbC in the correct redox 
state (Bessette et al. 1999).  This pathway offers a restoration pathway for proteins that have 
been folded into non-native conditions allowing for the re-formation of viable proteins. 
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Figure 1.5. The active efflux of cystine and glutathione enables the correct formation of disflphide bonds through the Dsb pathway, faciliting both the 
formation of disluphide bonds (DsbAB pathway) and the correct isomerisation of dislphuide bonds within proteins (DsbCD pathway). 
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1.8. Metal tolerance in E. coli 
Metals can be essential for bacteria in low concenctrations. However, in high concentration 
metal cations offer a wide range of destructive affects, i.e. the removal of strucutal metals, 
destruction of Fe-S clusters and the oxidation of redox active sites, allowing for the 
production of reactive oxygen speieces (ROS), thiol depletion and interference with nurtient 
uptake (Lemire, Harrison and Turner 2013). Originally resistance was though to be aquired 
through plasmids, simillarly to antibiotic resistance. Nonetheless, analysis of bacterial 
genomes revealled genomic proteins belonging to three major classes of efflux pumps, 
Resistacne-Nondulation-cell Division (RND) protein family, the Cation Diffusion 
Facillitator (CDF) family and P-type ATPase family (Lemire, Harrison and Turner 2013). 
Production of these classes of proteins offer methods to reduced intake of metal cations, and 
also active and passive efflux of cations based on chemiosmotic potential. Recent work has 
identified many alternative resistance mechanisms, including alteration of metabolic 
pathways by bacteria, production of chapereons, production of antioxidants, and expression 
of enzymes responsible for restore disulphide bond restoration (Harrison et al. 2004; 
Harrison et al. 2009; Lemire, Harrison and Turner 2013). To sequesteration of metals within 
the periplasm and exportation into extracellular environments within siderophores through 
unknown biochemical pathways (Macomber, Rensing and Imlay 2007).  
1.9. Investigations in the novel functions and haem binding site of CydDC 
This study aims to identity the relationship between CydDC and haem, as well as to 
characterise the novel haem co-factor identified in previous studies, as described in. Section 
1.2. It had been previously hypothesised that the haem binding domain resides on the 
periplasmic loop of CydD at residue His51.Therefore, it is hypothesised that site directed 
mutagenesis of His51 will remove the haem binding domain and purification of mutated 
CydDC will no co-purify with haem. 
Additionally, this study aims to assess the functionality of CydDC in the transportation of 
GSH-metal conjugates as a novel biochemical method for exerting metal tolerance within E. 
coli. Section 1.8. describes the importance of metal resistance in bacteria and the 
sequestration of metal ions within the periplasm through unknown biochemical pathways. It 
is known that GSH can form metal-GSH conjugates and evidence indicating strains of yeast 
and Leishmania can form GSH metal conjugates (Li et al. 1996; Dey et al. 1996). It is 
therefore hypothesised that E. coli can form GSH-metal conjugates which are transported 
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via CydDC into the periplasm for either diffusion across the membrane or sequestration 
within the periplasm as a form of metal tolerance.  
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MATERIALS AND 
METHODS 
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2.1. Bacteriological Methods 
All materials used within this thesis were obtained from Fisher Scientific or Sigma Aldrich 
unless specified. Yeast extract, Tryptone and nutrient agar were purchased from Melford. 
Sterilisation of growth media was performed through autoclaving at 121 oC, 15 psi, for 20 
minutes.  
2.1.1. Bacterial Strains 
Table 2.1. E. coli bacterial strains used in this work. 
Strain ID Description Source 
MS2 K-12 MG1655 Bachmann 1996 
MS8 BL21 (DE3) pLysS Bachmann 1996 
MS14 MG1655 cydDC::Cm Shepherd Laboratory 
MS48 BL21 (DE3) pLysS and pX100 Yamashita, 2015 
MS85 MG1655 cydDC::Cm pRKP1602 Holyoake, 2015 
MS462 BL21 (DE3) pLysS and His51Ala pHX100 This work 
 
2.1.2. Plasmids 
Table 2.2. List of plasmids used in this work 
PLASMID ID FEATURES REFERENCE 
pHX100 LacI, AmpR, CydDC-His6 Tag Yamashita, 2015 
pLyss  p15A_origin, CamR, TetR Bachmann 1996 
pHX100-H51A  LacI, AmpR, CydDC-H51A-His6 Tag  This work 
pRKP1602  CydDC, AmpR Pittman 2005  
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2.1.3. Oligonucleotide sequences 
Oligonucleotides Table 2.3. were designed in Vector NTI™ in accordance to specifications 
for desired kits, or protocols outlined by manufactures or outsources companies.   








































2.1.4. Growth media 
2.1.4.1. Luria Bertani (LB) media  
LB media contained 10 g Tryptone, 10 g NaCl, 5 g Yeast extract per litre of distilled-
deionised water.  
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2.1.4.2. M9 minimal media  
One litre of 20x M9 salts contained; 140 g Na2HPO4, 60 g KH2PO4, 10 g NaCl and 20 g 
NH4Cl. M9 media contained 50 mL of M9 salts, 2 mL 0.1M CaCl2, 4 mL 50% glycerol, 2 
mL 1 M MgSO4 and 20 mL 10% (w/v) casamino acids. 
2.1.4.3. SOC medium 
SOC media was prepared by adding 20 g Tryptone, 5 g Yeast extract, 0.584 g NaCl and 
0.186 g KCl within 970 mL of distilled-deionised water and autoclaved. Once cooled 10 
mL of Mg2+ solution (20.33 g MgCl2, 25.65 g MgSO4, dissolved in 100 mL of distilled-
deionised water and filter sterilised), and 20 mL 1 M glucose (filter sterilised). 
2.1.5. Media supplements 
2.1.5.1. Antibiotics 
Growth media were supplemented, where indicated, within working concentrations of 
antibiotic, Table 2.4. 
Table 2.4. Stock and working concentrations of antibiotics used throughout this project, 
listing the liquid used to solubilise the antibiotics in the far column. 
Antibiotic Stock concentration Working concentration Solubilised with 
Ampicillin 125 mg/mL 100 µg/mL Water 
Chloramphenicol 35 mg/mL 25 µg/mL Ethanol 
 
2.1.5.2. Nutrient agar 
One litre of LB medium, 15 g of dried nutrient agar.  
2.1.5.3. Casamino acids 
A 5% (w/v) stock solution of casamino acids was prepared by dissolving 5 g of dried 
casamino acids in 100 mL of distilled deionised water, then autoclaved as predefined 
sterilisation settings and left to cool.  
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2.1.5.4. Isopropyl b-D-1-thiogalactopyranoside (IPTG) 
To 10 mL of sterile MilliQ water, 2.83 g of IPTG was added and whirlmixed till dissolved 
to create a 1 M solution. The 1 M IPTG solution was then filter sterilised using 0.2 µ filters 
and aliquoted into 1 mL samples, and stored at -20 oC until needed.   
2.1.6. Bacterial growth conditions 
Bacteria were grown in LB media or on LB-agar, supplemented with appropriate working 
concentrations of antibiotics, where necessary. Growth was carried out at 37 oC, stationary 
or at 180 rpm, for solid cultures, and liquid cultures respectively.  
2.1.7. Metal efflux disc diffusion assay 
Four morphologically similar colonies where used to inoculate 5 mL of LB-media containing 
appropriate antibiotics, and incubated at 37 oC and 180 rpm until a the visual turbidity was 
equal or greater than that of a 0.5 McFarland Standard (Andrews 2001). When necessary, 
density was adjusted to that of the standard using sterile milliQ water.  
Cell suspension was diluted 1:100 in sterile Milliq® water, and the inoculum was spread 
evenly over the entire surface of a LB-agar plate with the aid of a sterile cotton swab. Filter 
paper discs, 5 mm in diameter created from filter paper (Whatman™ 1001-185), were 
inoculated with 5 µL of metal solution then applied directly to the agar. Plates were 
incubated at 37 oC overnight. Zones of inhibition were measure, with the diameter of the 
disc subtracted from the total diameter of the zone of inhibition.  
2.1.7.1. Zinc ion solution 
A 1 Molar Zinc Sulphate solution contained 1.61 g dissolved within 10 mL of distilled 
deionised water. 100 mM, 50 mM and 10 mM solutions were created through diluting 
stock 1 M zinc solution with required distilled deionised water, all solutions were filter 
sterilised using a 0.22 µm Millipore filter.  
2.1.7.2. Cadmium ion solution 
A 1 Molar cadmium sulphate solution contained 2.08 g dissolved within 10 mL of distilled 
deionised water. 100 mM, 50 mM and 10 mM solutions were created through diluting 
20 | P a g e  
 
stock 1 M zinc solution with required distilled deionised water, all solutions were filter 
sterilised using a 0.22 µm Millipore filter.  
2.1.8. Bacterial growth for CydDC expression  
An overnight in M9 media of strain MS48 or MS462, was used to inoculate 50 mL of fresh 
M9 media supplemented with 0.1% casamino acids and the appropriate antibiotics (Table 
X) in a 1:100 ratio. The new culture was incubated at 37 oC, 180 rpm until Optical Density 
(OD) at 600 nm was approximately 0.600. When desired OD was reached, 1 mL samples 
were aspirated and pelleted, and 0.6 mM IPTG was added. The bacterial culture was further 
incubated at 30 oC, 180 rpm for 4 hours. After 4 hours, 1 mL samples were aspirated and 
pelleted. 
2.1.9. Chemically competent cells  
An overnight of desired strain was used to inoculate 100 mL of fresh LB-medium, 
supplemented with appropriate antibiotics, at a 1:100 ratio and grown at 37 oC, 180 rpm until 
OD 660nm reached 0.4 ABS. When desired OD was achieved, cells were chilled on ice for 
10 minutes. Cells were then harvested at 3,000 rpm, 4 oC for 8 minutes before being re-
suspended in 25 mL 100 mM CaCl2, then returned to chill for 10 minutes on ice. Cells were 
then re-harvested at 3,000 rpm, 4 oC for 8 minutes and re-suspended in 2 mL CaCl2 and 30% 
(v/v) glycerol. Afterwards cells were aliquoted into 100 µL samples for single time use and 
stored at -80 oC. 
2.1.10. Plasmid DNA transformation 
Chemically competent cells, prepared as per Section 2.1.9. were thawed on ice before 10 µL 
of plasmid DNA was aspirated onto the cells. Cells were then left to incubate on ice for 30 
minutes. Upon end of incubation, cells were heat-shocked at 42 oC for 90 seconds precisely 
before returning to ice for incubation for 2 minutes. 900 µL of SOC media  (Section 2.1.4.3) 
was aspirated onto the cells, and they were further incubated at 37 oC, 180 rpm for 1 hour. 
Upon end of incubation cells were pelleted and re-suspended in 100 µL  SOC media, the 
whole reaction was then plated on Nutrient agar (Section 2.1.5.2.) supplemented with 
appropriate antibiotics. 
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2.2. Genetic Methods 
2.2.1. Plasmid DNA isolation 
A 10 mL overnight of strains containing desire plasmid was subjected to plasmid extraction 
using the QiaPREP spin miniprep kit (Qiagen) according to manufacturer’s instructions.  
 2.2.2. Gel electrophoresis 
Gel electrophoresis was performed using a 1% (w/v) agarose gel, submerged in a 1x TAE 
buffer (40 mM Tris acetate, 1 mM EDTA). DNA was mixed in a 5x loading buffer at a 
DNA:Buffer ratio of 1:5, before loading. The gel was run 150 v, 300 mA, for 25 mins, using 
Hyperladder I (Bioline) as a marker. Gel was stained with 5 µL ethidium bromide (10 mg/mL 
stock) (Sigma Aldrich) in 100 mL distilled deionised water for 30 minutes before 
visualisation on a Sysgene G box. 
2.2.3. Site directed mutagenesis of fragment 
Extracted pHX100, as per section 2.2.1 was subjected to a mutagenic PCR reaction using 
primers 174 and 175, Table 2.3. PCR reaction was set up as a 25 µL total reaction consisting 
of: 12.5 µL 2x Q5 master mix, 1 µL pHX100 (10 ng/ L), 1.2 µL 174 primer (10x stock), 1.2  
µL 175 primer (10x stock), 9  µL milliQ water, then run on the following programme settings 
Table 2.5. 
Table 2.5. PCR programme for amplification of H51A cydDC fragment, with use of Q5 
polymerase (New England Biolabs).  
Segment Cycles Temperature Time 
1 1 95 oC 1 minute 
2 35 95 oC 15 seconds 
72 oC 15 seconds 
72 oC 8 min 
3 1 72 oC 2 min 
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The PCR fragment was then quantified via gel electrophoresis, Section 2.2.2. The remaining 
PCR product was then cleaned using a PCR purification kit (Qiagen) according to the 
manufacturer’s instructions. 
2.2.4. Molecular cloning  
The extracted pHX100, as per section 2.2.1, and mutated PCR fragment, Section 2.2.3 were 
digested using HindIII (Promega), as per manufacturer’s instructions. Digested DNA 
samples were cleaned using a PCR purification kit (Qiagen) according to the manufacturer’s 
instructions and then digested a second time with StuI (New England Biolabs). After 
performing the second digests, the whole reaction of pHX100 was processed by gel 
electrophoresis, Section 2.2.2, the 4500 bp vector was gel extracted using the Gel Extraction 
Kit (Qiagen), and the mutated PCR fragment was PCR cleaned using the PCR purification 
kit (Qiagen). 
Ligation reactions were set up using T4 DNA ligase (Promega) with a ratio of 3:1 of 
fragment:vector and incubated overnight at room temperature. Ligated plasmids were then 
transformed, Section 2.1.10 into BL21 (DE3) competent cells, Section 2.1.9. 
2.2.5. Colony PCR 
Briefly, a colony was re-suspended in 50 µL of miliQ water and boiled for 10 minutes at 95 
oC. 2 µL of boiled supernatant was added to 12.5 µL taq master mix red (PCR BIO), 1.25 
µL primer 166 (10x working stock), 1.25 µL primer 167 (10x working stock), 9 µL milliQ 
water, then run on the following programme settings Table 2.6. 
Table 2.6. PCR programme for colony PCR of H51A vartiation cydDC fragment in 
pHX100. 
Segment Cycles Temperature Time 
1 1 95 oC 4 minute 
2 35 95 oC 15 seconds 
55 oC 15 seconds 
72 oC 15 sec/kb 
3 1 72 oC 2 min 
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PCR products were then analysed by gel electrophoresis, Section 2.2.2. 
2.2.6. Digestion assay and sequencing 
Positive colonies from colony PCR (Section 2.2.5.) were grown overnight in 10 mL LB-
media at 37 oC and underwent plasmid extraction, Section 2.2.1. Extracted plasmid was then 
digested with HindIII (Promega, R6401) to confirm plasmid size through visualisation, 
before digestion with NdeI (Promega, R6801). Colonies with a single cut were then prepared 
for sequencing with Genewiz™ as per company guidelines.  
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2.3. Biochemical Methods 
2.3.1. Purification of the CydDC complex 
An overnight of strain MS48 or MS462 in LB medium was used to inoculate fresh LB media, 
supplemented with the appropriate antibiotics, in a 1:50 ratio and incubated at 37 oC, shaking 
200 rpm. This overnight culture was then used to inoculate 1 L of M9 media, supplemented 
with 0.2% casamino acids and appropriate antibiotics, in a 1:100 ratio. Incubation was 
carried out at 37 oC, 220 rpm until OD600nm reached 0.6, at which 0.6 mM IPTG was added 
to induce expression of CydDC. After addition of IPTG, incubation was continued at 30 oC, 
220 rpm for a further 4 hours.  
Cells were then harvested by centrifuging for 20 min at 4,000 rpm, 4 oC. The pellet was re-
suspended in 120 mL of Tris-HCl (pH 7.4), 2 mM MgCl2 and 1 mM EGTA. Re-suspended 
cells were sonicated at 15µ for 6x30 seconds on ice, centrifuged for 15 min at 8,000 rpm, 15 
oC. Supernatant was then subjected to ultra-centrifugation for 1 h at 41,000 rpm, 4 oC to 
pellet membranes. Membrane pellets were re-suspended in 4mL Tris-HCl (pH7.4), 2 mM 
MgCl2 and 1 mM EGTA. 22.3 mL membrane extraction buffer (Tris-HCl pH 8.0, 20% 
glycerol, 300 mM NaCl, 10 mM Imidazole, and 1% DDM) was added to the re-suspended 
membrane pellets and incubated on ice, gently shaking for 1 h. Insoluble membranes were 
pelleted by ultra-centrifuging for 1 h at 37,000 rpm, 4 oC. Supernatant was then mixed with 
1.4 mL equilibration buffer (Tris-HCl pH 8.0, 20% glycerol, 5 mM Imidazole, 500 mM KCl 
and 0.1% DDM). 
5mL Ni-NTA was incubated with supernatant at 4oC for 2 h with constant mixing. Resin 
was then cast in a polypropylene column to give a bed of 2.5 mL. Supernatant and 
equilibration buffer solution were then passed through the column, and the flow through 
collected as 1 mL samples. The column was washed with 10 column volumes of purification 
buffer (Tris-HCl pH 8.0, 20% glycerol, 500 mM KCl, 5 mM Imidazole and 0.1% DDM) 
with flow though collected. The column was then washed with 10 column volumes of 
purification buffer (Tris-HCl pH 8.0, 20% glycerol, 500 mM KCl, 10 mM Imidazole and 
0.1% DDM) with flow though collected in 1 mL samples. Column was then washed with 10 
column volumes of purification buffer (Tris-HCl pH 8.0, 20% glycerol, 500 mM KCl, 20 
mM Imidazole and 0.1% DDM) with flow though collected. Protein was then eluted from 
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the column using elution buffer (Tris-HCl pH 8.0, 20% glycerol, 500 mM KCl, 300 mM 
Imidazole, and 0.02% DDM).  
 
 
Figure 2.1. Overview of CydDC purification process adapted from Yamashita et al (2015).  
 
2.3.2. SDS-PAGE gel analysis 
Purified proteins and plasmid induction tests were analysed by SDS-PAGE gels. A 4% 
stacking gel was cast on top of a set 10% resolving gel, recipe in Table 2.6. Cast gels were 
used on day of creation. Gel apparatus was submerged within SDS running buffer (25 mM 
Tris, 250 mM Glycine, 0.1% SDS, at pH 8.3).  
Table 2.II.7. Recipe for 10% SDS-PAGE gel used in this work. 
Chemical 10% Resolving Gel 4% Stacking Gel 
Water 3.8 mL 3.1 mL 
40% Bis-Acrylamide 2 mL 0.5 mL 
10% SDS  0.08 mL 0.05 mL 
10% APS 0.08 mL 0.05 mL 
TEMED 0.008 mL 0.005 mL 
Resolving Buffer (1.5 M Tris-HCl, 
pH 8.8) 
2 mL 0 mL 
Stacking Buffer (0.5 M Tris-HCl, 
pH 6.8) 
0 mL 1.25 mL 
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Samples were mixed in a 1:1 ratio with SDS loading buffer (50 mM Tris, 2% SDS, 0.1% 
Bromophenol blue, 10% glycerol and 100 mM DTT) and boiled at 95 oC for 5 minutes. Once 
boiled, samples were loaded onto gel, with a BIO RAD Precision Protein marker, and run at 
165 V for 40 minutes. Gels were then removed from apparatus and stained with 
InstantBlue™ for 1 hour.  
2.3.3. PVDF transfer and western blot 
Section 2.3.2. was followed until gel was removed from apparatus, at which point the 
separated proteins were transferred to a (methanol –activated) PVDF membrane (BIO 
RAD) using a wet transfer apparatus, at 100V for 1 hour. Membranes were blocked for 1 
hour in Blotto (137 mM Sodium chloride, 10 mM Tris, 5% Skimmed milk powder, 0.1% 
Sodium azide, at pH 7.4), followed by 1 hour incubation with 2 µL  of His6 Tag Antibody 
(ABCam) in 10 mL of fresh Blotto solution. Membrane was washed in 1x TBST (137 mM 
Sodium chloride, 10 mM Tris, 0.1% Tween 20, at pH 7.4) for 5 minutes. This step was 
repeated a total of 5 times. Subsequently, the membrane was developed for 10 minutes 
using 1x BCIP/NBT (Sigma Aldrich), used as per manufacturer’s instructions. To stop the 
development, the membrane was washed in distilled, deionized water for 5 minutes and 
then left to dry. 
2.3.4. Protein buffer exchange and quantification 
Eluted fractions containing CydDC were concentrated using a viva-spin concentrator (10 
kDa cut off), at 6687 rpm for 15 mins. A PD10 desalting column (GE healthcare) was 
equilibrated with 30 mL of protein storage buffer (20 mM Tris-HCl (pH 8.0), 0.05% DDM). 
Concentrated CydDC was passed through the column, followed by 5 mL of protein storage 
buffer. Eluted fractions were collected and analysed via UV-vis spectroscopy (Cary 60 UV-
Vis, Agilent Technologies) in a quartz cuvette (240-700 nm at 600 nm/min). 
Buffer-exchanged protein was then quantified using a Markwell assay as previously 
described (Markwell et al. 1978). Briefly, reagent A (20 g/L Na2CO3, 4 g/L NaOH, 1.6 g/L 
Sodium Tartrate and 10 g/L SDS) was mixed with reagent B (4% CuSO4.5H2O) in a 99:1 
ratio respectively, to form reagent C. 3 mL reagent C was whirl-mixed with 1 mL of protein 
(diluted 1:10), sterile Milli-Q water and a range of known concentrations of BSA to form a 
standard curve, and left to stand for 1 hour at room temperature. 0.3 mL of Folin (50% v/v/) 
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reagent was whirl-mixed into protein/reagent C solution and left to incubate for 45 minutes. 
Absorbance readings were measured at 660 nm. Concentrations of proteins were calculated 
from the standard curve and adjusted using initial dilution factor before calculating the molar 
concentration using the molecular weight of the protein. 
 
2.3.5. Tryptophan fluorescence titrations to analyse 
haem binding to CydDC 
Haem stocks were created via solubilising 1 mg of haemin (Sigma) with 1 mL dimethyl 
sulfoxide (DMSO) (Fluka) and subsequent dilution with water. For quantification, pyridine 
haemochrome spectra were collected essentially as described previously (Berry and 
Trumpower 1987). Haem solutions were then diluted 1:1 with 4.2 M pyridine containing 0.4 
M NaOH. This solution was then divided into two cuvettes with one containing a few grains 
of sodium dithionite and the other containing a few grains of potassium ferricyanide. 
Reduced-oxidised absorbance spectra was measured between 600 nm and 500 nm. Using 
the Beer-Lambert equation (a = ecl) concentrations of haem were calculated using the 
differences between the peak (at 557 nm) and trough (at  541 nm) using the extinction 
coefficient Ɛ557-541 = 20.7 mM-1cm-1 (Falk and Smith 1975). 
100 nM CydDC was prepared following quantification from with Markwell assay (Section 
2.2.4). Fluorescence titrations were performed using 2 mL of 100 nM CydDC in a quartz 
cuvette. Quantified haemin solution in protein storage buffer was prepared at concentrations 
of 0.1 µM to 0.5 µM, and mixed thoroughly. Protein fluorescence was scanned between 310 
nm to 400 nm at a speed of 250 nm/min, with initial excitation set to 280 nm, with emission 
and excitation slits set to 5 nm. Haemin was added to the cuvette in small volumes and the 
solution was left for 1 min before fluorescence emission scans were recorded. Titrations 
were carried out until the change in fluorescence had diminished significantly. Control 
titrations were performed under the same conditions with n-acetyl-tryptophanamide 
(NATA) replacing CydDC. The concentration of NATA was adjusted accordingly to match 
the initial maximum fluorescence of 100 nM CydDC with 0 µM haemin.  
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3.1. Site-directed mutagenesis of the putative haem-
binding residue His51 in CydD 
3.1.1 Mutagenesis of pHX100 and preliminary plasmid analysis 
As introduced in Section 1.5, His51 of CydD is a potential haem-binding residue. In order 
to generate a plasmid vector to express this variant in E. coli, the pHX100 plasmid (Figure 
3.1A) encoding wild type CydDC (with a C-terminal His6-tag on CydC) was subjected to 
mutagenesis using the PCR and conventional cloning method detailed in Section 2.2.3. In 
brief, mutagenic primers were used to amplify a modified cydDC fragment using pHX100 
as a template (Figure 3.1B). This purified PCR product was then cut using HindIII and StuI. 
The pHX100 plasmid was then digested with HindIII and StuI   and the 4.5 kbp fragment 
was gel extracted (Figure 3.1C), and the cut vector and insert were quantified on an agarose 
gel using marker bands of known size and concentration (Figure 3.1D) (Section 2.2.4).  
A 
Figure 3.1. Mutagenic PCR of pHX100 to form H51A variant. A) Plasmid map of WT 
pHX100. B) Mutagenic PCR product following alongside cut pHX100 plasmid for digest 
with StuI. C) Double digest of WT pHX100 plasmid in preparation of fragment insertion. 
D) Quantification of prepared vector and mutagenic fragment using Hyperladder I (BIO 
LINE) in preparation of ligation.  
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Ligations were then performed (Section 2.2.4) and competent BL21 (DE3) cells were 
transformed with the ligation mixture (Section 2.1.10). Colony PCR (Section 2.2.5.) was 
used to identify positive colonies, namely colonies 8, 18 and 19 as containing a pHX100 
plasmid (Figure 3.2). Plasmid DNA of these colonies was mini-prepped (see section X) and 
digested with HindIII and NdeI, to determine if the H51A mutation was present in the cydD 
gene (Figure 3.3.). The mutation primers were designed in such a way that if the plasmid 
encodes the desired mutation, digestion with HindIII and NdeI will yield a single fragment 
of 8.05 kbp, whereas the wild type plasmid will yield fragments of 3.38 kbp and 4.67 kbp 
(i.e. mutation removes the NdeI site). The restriction digest on plasmid isolated from colony 
8 produced a 8.05 kbp fragment when digested with HindIII alone or a HindIII/NdeI double 
digest, revealing the absence of NdeI site associated with the H51A mutation. A single digest 
with NdeI failed to linearize the plasmid, further suggesting the presence of the desired 
H51A mutation.  
Figure 3.2. Colony PCR screening of transformants for the presence of pHX100. Ligation 
transformant colonies were subjected to colony PCR using primers that specifically amplify 
a 2000 bp fragment of pHX100. 





Figure 3.3. Restriction digest screening for the pHX100 plasmid encoding the cydDC H51A 
variant. M= Marker, U= Undigested, H= HindIII digest, N= NdeI Digest, D= Double Digest 
with HindIII and NdeI. Colony 8 lacks the NdeI site and is therefore likely to encode the desired 
H51A mutation. 
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3.1.2. Sequencing of the H51A mutation in pHX100   
Plasmid isolated from colony 8 (Section 2.2.1) was sequenced via Sanger sequencing at 
Genewiz™. Data was then analysed through slignment with Bioedit v7.2.5, revealing that 
the cydD codon 51 (CAT) encoding histidine had indeed been changed to GCT, which 
encodes alanine upon (Figure 3.4A). Analysis of the translated sequence using the Snapgene 
program revealed that the mutant H51A codon was in frame with the start codon, with a 











Figure 3.4. Sequencing data for the pHX100 cydDC H51A plasmid. Plasmid from colony 8 
was sequenced using primers 166, 44 and 45. A) Sequencing results revealed C426G and 
A427C mutation after start codon. B) Translation of the sequence data demonstrated the desired 
H51A mutation is encoded in frame with the start codon. 
A 
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3.2. Isolation and analysis of purified CydDC 
3.2.1 Overexpression and purification of wild type CydDC 
E. coli CydDC, containing a C-terminal His6-tag, was overexpressed in E. coli BL21 cells 
and purified by affinity chromatography (Section 2.3.1). Purity of CydDC was analysed 
using a 10% SDS-PAGE gel (Section 2.3.2). Results obtained show high purity of CydDC, 
shown within the purified protein lane by the presence of two proteins migrating at a rate 
corresponding to approximately 55 kDa. This suggests the presence of CydDC (Figure 
3.5A): the calculated molecular weight CydD and CydC are 65 kDa and 63 kDa, 
respectively, and these membrane proteins have previously been shown to migrate at a 
slightly faster rate compared to soluble proteins of the same size (Yamashita et al. 2014). To 
confirm the identity of CydC on the gel, a Western blot was performed (Section 2.3.3) using 
an anti-His6-tag antibody from AbCam (Figure 3.5B). Results from the Western blot 
revealed His6-tagged protein in both the supernatant and the purified protein lanes, at a 
molecular weight corresponding to CydC. 
A B 
Figure 3.5. SDS-PAGE and Western blot analysis of CydDC purification. A) 
Samples collected during CydDC protein purification were resolved on a 10% SDS-
PAGE gel. The presence of two proteins migrating at a rate corresponding to 
approximately 55 kDa in the purified protein lane suggests the presence of CydDC. B) 
Western blot analysis of protein purification samples probed with anti-His6-tag 
antibody (Abcam) detected His6-tagged CydC protein in supernatant and purified 
protein fractions. As a positive control, a previously characterised His6-tagged HemE 
protein was used.   
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3.2.2 Attempts to overexpress and purify H51A CydDC 
Plasmid induction tests were performed within BL21 (DE3) pLysS strains harbouring 
pHX100 plasmids encoding either wild type CydDC or the or H51A mutant CydDC. Cells 
were grown as described in Section 2.1.8 and whole cells were loaded onto 10% SDS-PAGE 
gels, transferred to PVDF membrane and probed with antibody specific to His6- tagged 
protein (Section 2.3.2). The Western blot shows that induction with IPTG for 4 hours 
induced expression of wild type CydC (Figure 3.6A), whereas a similar induction for the 
H51A mutant CydDC complex did not result in the expression of CydC (Figure 3.6B). 
Nevertheless, protein purifications were attempted in order to isolate CydDC H51A mutant, 





Figure 3.6. Induction tests to monitor CydC expression via Western blotting. A) Induction 
of wild type CydDC (A) and H51A CydDC (B) with IPTG followed by detection of CydC 
using anti His6-tag antibodies. 
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3.2.3. Spectroscopic analysis of purified CydDC 
UV/vis spectroscopic analysis of purified wild type E. coli CydDC revealed absorbance 
peaks at 280 nm and 415 nm (Figure 3.7), corresponding to CydDC protein and bound haem 
as previously reported (Yamashita et al. 2014). A Markwell assay (Section 2.3.4) revealed 




Figure 3.7. UV/vis spectrum of purified wild type CydDC. Peaks at 280 nm and 415 nm 
are due to absorbance of protein and haem, respectively. 
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3.3. Haem affinity measurements for CydDC 
Haem has previously been shown to bind to CydDC, so it was of interest to measure the 
affinity of this interaction. CydDC tryptophan fluorescence titrations were performed as 
described in Section 2.3.5 along with control titrations with the fluorescent small molecule 
N-acetyl-tryptophanamide (NATA). Fluorescence emission spectra demonstrated quenching 
in the 430 nm peak upon titration of CydDC with haemin (Figure 3.8A), and the control 
experiment with NATA also exhibited quenching (Spectra shown in Appendix C), 
presumably due to the absorbance of fluorescence emission by the haem ligand. The 
magnitudes of these peaks are plotted on the same graph (Figure 3.8B), which suggested a 
linear response for the NATA control whereas the CydDC titration appeared to have a 
hyperbolic component. The linear control data was subtracted from the CydDC data to reveal 
a hyperbolic transition that was solely due to haemin binding to CydDC (Figure 3.8C). To 
estimate a Kd value, these data were fitted to equation 1 using nonlinear regression 
(Sigmaplot), which yielded a dissociation constant of 0.32 ± 0.11 µM. 
 
Equation 1.  [L] is equal to haemin (ligand) concentration (i.e. X-axis values) and [E] is 
equal to concentration of CydDC (0.1 µM), F0 is the intercept (i.e. fluorescence at [haemin] 










Figure 3.8. Tryptophan fluorescence quenching to monitor haem hinding to CydDC. A) 
Change in fluorescence emission spectra upon haem binding to CydDC. Data recorded using 
excitation at 280 nm and emission scans at speed of 250 nm/min, with emission and 
excitations slits set to 5 nm. B) Change in fluorescence at 340 nm upon haem binding for both 
100 nM wild type CydDC and N-acetyl-tryptophanamide (NATA). C) 100 nM wild type 
CydDC titrated with haemin, with data normalised via subtraction of F data for NATA. The 
fitted binding curve predicts a Kd value for the CydDC/haem interaction as 0.32 µM.
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3.4. CydDC transports metal-bound Glutathione 
across the periplasmic membrane.  
To further investigate CydDC functionality in vivo, the contribution of this complex to metal 
tolerance was investigated. The CydDC substrate reduced glutathione (GSH) is well-known 
to bind to a variety of metal ions (Rubino et al. 2004; Rubino et al. 2006; Burford, Eelman 
and Groom 2005), so it was hypothesised that CydDC might provide protection to E. coli 
against metal toxicity via the export of GSH:metal conjugates. There is a precedent for this, 
as cadmium and aresenite have been reported to be exported as GSH conjugates in yeast  (Li 
et al. 1996) and Leishmania (Dey et al. 1996), respectively.  Disc diffusion assays (Section 
2.1.7.) were used to test the ability of CydDC to confer tolerance of E. coli to zinc and 
cadmium ions (Figure 3.9). An E. coli cydDC knockout strain showed a significant increase 
in zone of inhibition size to these metals compared to a wild type strains and a cydDC mutant 
strain complemented with the pRKP1602 CydDC expression vector. The complemented 
strain shows recovery to wild type susceptibility, and surprisingly no additional metal 
tolerance is provided by the presence of the cydDC locus on a multi-copy plasmid. 
 
A B 
Figure 3.9. Disc diffusion analysis of CydDC expression and metal tolerance. Wild type 
(WT), cydDC knockout mutant (CydDC::Cm), and complemented mutant (CydDC::Cm 
pRKP1602) E. coli strains were tested for tolerance to zinc (A) and cadmium (B). 
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4.1. Engineering a plasmid to express a H51A 
variant of CydDC 
It has recently been shown that the CydDC complex binds haem (Yamashita et al. 2014) and 
a good candidate for haem binding is the His51 residue on CydD (Shepherd 2015) It was 
therefore of interest to test the hypothesis that His51 binds haem by generating an expression 
construct for this mutant CydDC complex. This was successfully achieved via mutagenic 
PCR and conventional cloning in the expression vector pHX100 (Figures 3.1A-D, 3.2 and 
3.3), and the desired mutation was confirmed by Sanger sequencing (Figures 3.4, Appendix 
B). Prior to this, extensive efforts to introduce this mutation were made using the Q5 site 
directed mutagenesis kit (NEB), but after multiple failed attempts the aforementioned 
PCR/cloning approach yielded the desired vector. 
4.2. Expression, purification and antibody detection 
of the CydDC complex 
Expression of wild type CydDC was successfully achieved through the use of the expression 
vector pHX100, a high copy number plasmid containing a Ptac promoter upstream of the 
cydD gene (Appendix A). The Ptac promoter is a hybrid of the trpB and lac promoters, which 
offers high yield and tight regulation of transcriptional units. Cell growth was performed in 
M9 minimal media to reduce the chance of Ptac activation from Tryptone found in some 
growth media. Indeed, no expression of wild type CydDC was detected before the addition 
of the inducer IPTG (Figure 3.6), demonstrating that this promoter is not leaky when cells 
are grown in M9 medium.  
Analysis of the CydDC purification process was performed using SDS-PAGE, which 
revealed two proteins migrating at a rate corresponding to proteins of a lower molecular 
weight than the predicted 63 and 65 kDa that were expected. This has been observed before 
for CydDC (Yamashita et al. 2014), and it is not uncommon for membrane proteins to 
migrate at unusual rates on SDS-PAGE gels: the lower than expected molecular weight can 
be explained from the solubilisation and stabilisation of CydDC within micelles causing 
anomalous migration (Rath et al. 2009). Western blot analysis using an anti-His6-tag 
antibody confirmed the presence of CydDC in the supernatant and protein elution lanes, 
providing validation that the purified complex is indeed CydDC (Figure 3.5).  
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Unfortunately, attempts to overexpress and purify the H51A variant of CydDC were 
unsuccessful. Given the location of His51, within the periplasmic loop of CydD (Shepherd 
2015), it was anticipated that a H51A mutation would not perturb incorporation of CydDC 
in the cell membrane. However, the absence of CydDC H51A in expression and purification 
attempts analysed by SDS-PAGE and Western blotting confirm the absence of the CydDC 
complex. It is unlikely that the promoters and expression systems have been affected from 
the mutagenesis and cloning, as sequencing revealed no mutations within the Ptac promoter. 
Hence, the lack of detectable protein suggests that His51 provides an important role in 
CydDC assembly. 
 
4.3. CydDC has a high affinity for haem 
The original aim of this project was to purify wild type and H51A variant of CydDC for 
subsequent haem-binding analyses. Unfortunately, the mutant protein was not assembled in 
E. coli so haem-binding studies could only be performed on the wild type protein. Analysis 
of purified CydDC via UV-visible spectrophotometry revealed a broad peak centred around 
415 nm (Figure 3.7), indicating the presence of bound haem. This is consistent with previous 
reports that CydDC is co-purified from E. coli with haem b (Yamashita et al. 2014) 
Comparison between protein peak (280 nm) and the haem peak (~400 nm) indicates a ratio 
of 4:1 of protein:haem. This substoichiometric binding may be explained by a limited 
availability of haem in the cell.  
To further investigate this interaction, tryptophan fluorescence titrations were conducted 
with purified wild type CydDC and haemin, which revealed a Kd value of 0.32 µM +/- 0.11 
µM (Figure 3.8C). This confirms that CydDC has a high affinity to haem, and the co-
purification is unlikely to be due to nonspecific interactions. This study is consistent with 
previous studies of CydDC structural models which identified histidine and arginine residues 
on CydD that could potentially provide specific interactions with haem (Shepherd, 2015): 
hydrogen bonds may be formed between Arg47 and the carboxyl groups of b-type haem, 
along with an axial coordination of the central haem iron by His51. The high affinity between 
CydDC and haem suggests that haem is likely to play an important role within the 
functionality of CydDC in its reductant efflux. Given that the haem cofactor is redox active 
(Yamashita et al. 2014) and that CydDC exports redox active substrates (i.e GSH and 
cysteine) it is therefore proposed that haem may regulate the activity of CydDC through 
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sensing changes in redox poise, although further investigations are required to test this 
hypothesis.  
 4.4. New roles of CydDC in metal tolerance 
To investigate the ability of CydDC to export GSH:metal conjugates, disk diffusion assays 
were performed with zinc and cadmium. It was hypothesised that cells expressing CydDC 
would be better able to export these metals, and therefore be able to grow in the presence of 
higher external metal concentrations. The data in Figure 3.9 shows that E. coli cydDC strains 
exhibited a significant loss of tolerance to metal ions, in comparison to wild type and 
complemented strains. This data is consistent with the hypothesis that CydDC can export 
both GSH-Zn2+ and GSH-Cd2+, and are consistent with previous observations that ABC 
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4.5. Future work 
H51A CydDC expression may be affected from varying environmental factors such as 
growth medium, IPTG concentration and total viable cell mass. Therefore, protein 
expression needs to be investigated under varying conditions and analysed via Western blot 
using a His6 antibody as described in Section 2.3.3. If H51A CydDC variant protein is viable, 
further analysis through UV/vis spectroscopy and Tryptophan fluorescent titrations could 
confirm that His51 is the location of haem binding. It has also been shown that CydDC is 
required for cytochrome bd-I assembly (Shepherd 2015). CO difference spectras and 
reduced minus oxidised difference spectras of H51A mutants would offer an insight into the 
effect of bound haem in cytochrome bd-I assembly and accumulation of the unknown haem 
compound P-574.  
Previously shown in literature, CydDC is co-purified with bound haem at a haem:CydDC 
ratio of 1:4 (Yamashita et al. 2014). Current hypothesis suggest this substoichiometric ratio 
is due to bioavailability, and it would be interest to see if haem loading of CydDC can occur 
during the purification process, to achieve a protein:haem ratio of 1:1. This could in-turn be 
used to maximise redox potential within the periplasm for disulphide bond formation, that 
could be adapted to enhance recombinant protein production in E. coli. 
Finally, this work suggests a novel role for CydDC as a GSH:metal conjugate transporter, 
but further research with different metal ions is required to further support this hypothesis. 
Alongside future work into CydDC role in metal sequestration in the periplasm, 
investigations in the ATPase activity in the presence of GSH:metal conjugate could offer 
insight into the exportation process of conjugates into the periplasm. As well as the effects 
of GSH synthesis into CydDC-mediated tolerance of metals, which can be undertaken 
through the use of mutant gshA and gshA cydDC E. coli strains in disc diffusion assays 
outlined within Section 2.1.7.  
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Appendix A. Plasmid map of PHX100.- a wild type CydDC expression vector. 
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Appendix B. WT CydDC and H51A mutant sequencing data alignment, using Bioedit 
v7.2.5 software. Sequencing results revealed C426G and A427C mutation after start codon 
(ATG) located at base 296, with a Shine-Dalgarno (AGGA) sequence located at 258 bp, 
suggesting sequence. 




Appendix C. Change in fluorescence emission spectra upon haem addition to N-acetyl-
tryptophanamide (NATA). Data recorded using excitation at 280 nm and emission scans at 
speed of 250 nm/min, with emission and excitations slits set to 5 nm. 
 
